Please login to the form below

Not currently logged in
Email:
Password:

Vivid

This page shows the latest Vivid news and features for those working in and with pharma, biotech and healthcare.

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial

Today’s BE SURE findings are consistent with the positive results we recently announced for both BE VIVID and BE READY,” said Iris Loew-Friedrich, head of drug development and chief ... This includes a recent phase 3 BE VIVID study comparing the drug

Latest news

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 20 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...

Infographics